Publication in detail

European journal of immunology 2014 Jan 28. doi: 10.1002/eji.201344063. [Epub ahead of print]

Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-1β secretion from monocytes and macrophages.

Chaly, Y; Fu, Y; Marinov, A; Hostager, B; Yan, W; Campfield, B; Kellum, JA; Bushnell, D; Wang, Y; Vockley, J; Hirsch, R

Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, USA.

Abstract:
Follistatin-like protein 1 (FSTL-1) is overexpressed in a number of inflammatory conditions characterized by elevated IL-1β. Here we found that FSTL-1 serum concentration was increased three-fold in patients with bacterial sepsis and four-fold following administration of lipopolysaccharide (LPS) to mice. To test the contribution of FSTL-1 to IL-1β secretion, wild-type and FSTL-1-deficient mice were injected with LPS. While LPS induced IL-1β in the sera of wild-type mice, it was low or undetectable in FSTL-1-deficient mice. Monocytes/macrophages, a key source of IL-1β, do not normally express FSTL-1. However, FSTL-1 was found in tissue macrophages after injection of LPS into mouse footpads, demonstrating that macrophages are capable of taking up FSTL-1 at sites of inflammation. In vitro, intracellular FSTL-1 localized to the mitochondria. FSTL-1 activated the mitochondrial electron transport chain, increased the production of ATP (a key activator of the NLRP3 inflammasome) and IL-1β secretion. FSTL-1 also enhanced transcription of the NLRP3 and pro-caspase-1 genes, two components of the NLRP3 inflammasome. Adenovirus-mediated overexpression of FSTL-1 in mouse paws led to activation of the inflammasome complex and local secretion of IL-1β and IL-1β-related proinflammatory cytokines. These results suggest that FSTL-1 may act on the NLRP3 inflammasome to promote IL-1β secretion from monocytes/macrophages. This article is protected by copyright. All rights reserved.

» Online Version

Proven Track Record

The team at Ozgene has over two decades of experience creating customised knockout and knock-in mice for pivotal medical research globally. Over 350 scientific publications are based on research using Ozgene mice.

Go to Publications

Global Client Base

Ozgene generates genetically customised mice for researchers around the world. Ozgene mice can be found in 31 different countries on 5 continents from small academic institutions to multinational pharmaceutical companies.

See Map

Lean Management

Ozgene is applying Lean Management principles to deliver the highest quality services and shortest lead times to our customers. The implementation of Lean Culture has already seen an improvement in our processes and timelines.

Read More